Tranexamic Acid Administration for Stroke

Dosing Recommendations

• The recommended dose of tranexamic acid for stroke is a loading dose of 1 g intravenously over 10 minutes, followed by an intravenous infusion of 1 g over 8 hours, and should be given as soon as possible and within 3 hours of symptom onset, as recommended by the American College of Critical Care 1
• Current guidelines do not specifically recommend TXA for ischemic stroke, according to the American Heart Association/American Stroke Association 4

Timing Considerations

• Effectiveness of TXA decreases by approximately 10% for every 15-minute delay in administration, as stated by the European guidelines 2
• Administration should occur as soon as possible after onset of bleeding, as recommended by the Critical Care society 1
• Administration after 3 hours post-injury may increase risk of death due to bleeding, according to the Praxis Medical Insights guidelines 3

Route of Administration

• Intravenous administration is the recommended and evidence-based route, as stated by the Critical Care society 1
• Current guidelines do not include specific recommendations for intramuscular dosing of TXA, according to the Praxis Medical Insights guidelines 2

Safety Considerations

• Higher doses of TXA are associated with increased risk of seizures, particularly in cardiac surgery patients, as reported by the Praxis Medical Insights guidelines 3
• Blood pressure should be monitored and controlled during administration, as recommended by the American Heart Association/American Stroke Association 4

Special Populations

• For traumatic brain injury, TXA has shown benefit in reducing head injury-related death when administered within 3 hours, particularly in mild to moderate TBI, as stated by the Praxis Medical Insights guidelines 3
• Early treatment with TXA showed reduction in mortality in mild and moderate head injury but not in severe head injury, according to the Critical Care society 1

Common Pitfalls

• Delaying administration beyond 3 hours significantly reduces effectiveness, as reported by the Praxis Medical Insights guidelines 3
• Using TXA in ischemic stroke patients who are candidates for thrombolytic therapy could theoretically counteract the beneficial effects of thrombolytics, according to the American Heart Association/American Stroke Association 4